Want data on drugs? Look for clinical study reports

By Andrew M. Seaman NEW YORK (Reuters Health) – For information on how drugs work and affect people, a new study says regulatory reports that are rarely published are better sources than the typical documents that are publicly available. German researchers found that so-called clinical study reports produced by pharmaceutical companies had complete information on 86 percent of study outcomes that are relevant to patients. In contrast, only about 39 percent of those outcomes were found in other sources, such as studies published in academic journals. …